pull down to refresh

0 sats \ 0 replies \ @BlokchainB 18 Jun \ on: Nasdaq Chinese Herb Stock With NO Revenues Rallies 59,000% Market Cap of $36 bil Stacker_Stocks
Shares of Regencell Bioscience, a Hong Kong-based developer of traditional Chinese herbal treatments that it says can treat childhood ADHD and autism, more than tripled Monday. The stock soared more than 280% after a 38-for-1 stock split.
Hahaha!!! Definitely has to be some insider trading or something afoul
write
preview